Prescription Trends of Initial Pharmacotherapy for Benign Prostatic Hyperplasia Among Treatment‐Naïve Patients in South Korea: A Retrospective Analysis

Recent American Urological Association (AUA) guidelines recommend combination therapy as an effective strategy for reducing the risk of BPH-related complications. Although the largest proportion of patients was prescribed AB monotherapy, the growing adoption of combination therapy in South Korea, particularly among older age groups, suggests a shift toward more guideline-concordant and effective therapeutic approaches.